Scientific article
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths
ContributorsNeppl-Huber, C; Zappa, M; Coebergh, J W; Rapiti Aylward, Elisabetta; Rachtan, J; Holleczek, B; Rosso, S; Aareleid, T; Brenner, H; Gondos, A; EUNICE Survival Working Group
CollaboratorsUsel, Massimo
Published inAnnals of oncology, vol. 23, no. 5, p. 1325-1334
Publication date2012
Abstract
Keywords
- Adult
- Aged
- Aged, 80 and over
- Carcinoma/diagnosis/epidemiology/mortality
- Cause of Death/trends
- Diagnostic Techniques, Endocrine/statistics & numerical data/trends/utilization
- Europe/epidemiology
- Humans
- Incidence
- Male
- Mass Screening/methods/statistics & numerical data/trends
- Medical Oncology/methods/trends
- Middle Aged
- Prostate-Specific Antigen/analysis
- Prostatic Neoplasms/diagnosis/epidemiology/mortality
- Survival Analysis
- Survival Rate/trends
- United States/epidemiology
Citation (ISO format)
NEPPL-HUBER, C et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. In: Annals of oncology, 2012, vol. 23, n° 5, p. 1325–1334. doi: 10.1093/annonc/mdr414
Main files (1)
Article (Published version)
Identifiers
- PID : unige:44621
- DOI : 10.1093/annonc/mdr414
- PMID : 21965474
Journal ISSN0923-7534
